Bristol-Myers Squibb Co (WBO:BMYS) Other Long-Term Liabilities : €3,627 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co Other Long-Term Liabilities?

Bristol-Myers Squibb Co's other long-term liabilities for the quarter that ended in Mar. 2024 was €3,627 Mil.

Bristol-Myers Squibb Co's quarterly other long-term liabilities increased from Sep. 2023 (€3,377 Mil) to Dec. 2023 (€3,378 Mil) and increased from Dec. 2023 (€3,378 Mil) to Mar. 2024 (€3,627 Mil).

Bristol-Myers Squibb Co's annual other long-term liabilities declined from Dec. 2021 (€4,472 Mil) to Dec. 2022 (€4,054 Mil) and declined from Dec. 2022 (€4,054 Mil) to Dec. 2023 (€3,378 Mil).

Bristol-Myers Squibb Co Other Long-Term Liabilities Historical Data

The historical data trend for Bristol-Myers Squibb Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Other Long-Term Liabilities Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Bristol-Myers Squibb Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Bristol-Myers Squibb Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines